Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 12, 2014 - Issue 4
Submit an article Journal homepage
254
Views
83
CrossRef citations to date
0
Altmetric
Reviews

Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review

Maria-Jesús PinazoBarcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), 132 Rosello st 4°,08036, Barcelona, SpainCorrespondence[email protected]
,
M Carmen ThomasInstituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC). Parque Tecnológico de Ciencias de la Salud.Conocimiento av. 18100 Granada, Spain
,
Jacqueline BuaInstituto Nacional de Parasitologia Dr. Mario Fatala Chaben. ANLIS Carlos G MALBRAN. 68 Paseo Colón 1063, Buenos Aires, Argentina;Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 1917 Rivadavia av 1033 Buenos Aires, Argentina
,
Alina PerroneInstituto Nacional de Parasitologia Dr. Mario Fatala Chaben. ANLIS Carlos G MALBRAN. 68 Paseo Colón 1063, Buenos Aires, Argentina;Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 1917 Rivadavia av 1033 Buenos Aires, Argentina
,
Alejandro-Gabriel SchijmanLaboratorio de Biologia Molecular de la Enfermedad de Chagas INGEBI – CONICET, 2490 Vuelta de Obligado, Buenos Aires, Argentina
,
Rodolfo-Jorge ViottiCardiology Department, Hospital Eva Perón, 3200 Ricardo Balbín av. San Martín, Buenos Aires, Argentina
,
Janine-M RamseyCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, 19 Poniente esq 4 Sur, Tapachula, Chiapas 30700, México
,
Isabela RibeiroDrugs for Neglected Diseases Initiative, 15 Ch. Louis-Dunant 1202 Geneva, Switzerland
,
Sergio Sosa-EstaniInstituto Nacional de Parasitologia Dr. Mario Fatala Chaben. ANLIS Carlos G MALBRAN. 68 Paseo Colón 1063, Buenos Aires, Argentina;Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 1917 Rivadavia av 1033 Buenos Aires, Argentina
,
Manuel-Carlos LópezInstituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC). Parque Tecnológico de Ciencias de la Salud.Conocimiento av. 18100 Granada, Spain
&
Joaquim GasconBarcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), 132 Rosello st 4°,08036, Barcelona, Spain
 show all
Pages 479-496 | Published online: 12 Mar 2014

Citations (83)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Nieves Martínez-Peinado, Nuria Cortes-Serra, Irene Losada-Galvan, Cristina Alonso-Vega, Julio A. Urbina, Ana Rodríguez, John L. VandeBerg, Maria-Jesus Pinazo, Joaquim Gascon & Julio Alonso-Padilla. (2020) Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?. Expert Opinion on Investigational Drugs 29:9, pages 947-959.
Read now
Cristina Alonso-Vega, Irene Losada-Galván, María-Jesus Pinazo, Javier Sancho Mas, Joaquim Gascón Brustenga & Julio Alonso-Padilla. (2019) The senseless orphanage of Chagas disease. Expert Opinion on Orphan Drugs 7:12, pages 535-545.
Read now
Julio Alonso-Padilla, Nuria Cortés-Serra, María Jesús Pinazo, María Elena Bottazzi, Marcelo Abril, Fabiana Barreira, Sergio Sosa-Estani, Peter Jay Hotez & Joaquim Gascón. (2019) Response to `letter to the editor: ‘Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America’´. Expert Review of Anti-infective Therapy 17:9, pages 673-675.
Read now
Julio Alonso-Padilla, Nuria Cortés-Serra, María Jesús Pinazo, María Elena Bottazzi, Marcelo Abril, Fabiana Barreira, Sergio Sosa-Estani, Peter Jay Hotez & Joaquim Gascón. (2019) Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Review of Anti-infective Therapy 17:3, pages 145-157.
Read now
Jadel Müller Kratz, Facundo Garcia Bournissen, Colin J. Forsyth & Sergio Sosa-Estani. (2018) Clinical and pharmacological profile of benznidazole for treatment of Chagas disease. Expert Review of Clinical Pharmacology 11:10, pages 943-957.
Read now
Julio Alonso-Padilla, Montserrat Gallego, Alejandro G. Schijman & Joaquim Gascon. (2017) Molecular diagnostics for Chagas disease: up to date and novel methodologies. Expert Review of Molecular Diagnostics 17:7, pages 699-710.
Read now
Juan B. Rodriguez, Bruno N. Falcone & Sergio H. Szajnman. (2016) Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015). Expert Opinion on Therapeutic Patents 26:9, pages 993-1015.
Read now
Eric Chatelain & Nandini Konar. (2015) Translational challenges of animal models in Chagas disease drug development: a review. Drug Design, Development and Therapy 9, pages 4807-4823.
Read now

Articles from other publishers (75)

Mateo Morales‐Velásquez, Juan Pablo Barón‐Vera, María Isabel Osorio‐Pulgarín, Miryan Margot Sánchez‐Jiménez & Juan David Ospina‐Villa. (2023) Biomarkers for the diagnosis, treatment follow‐up, and prediction of cardiac complications in Chagas disease in chronic phase: Recent advances. Parasite Immunology 45:12.
Crossref
Alina E. Perrone, Mariana Pinillo, Marcela S. Rial, Marisa Fernández, Natalia Milduberger, Carolina González, Patricia L. Bustos, Laura E. Fichera, Susana A. Laucella, María Cecilia Albareda & Jacqueline Bua. (2023) Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency. International Journal of Molecular Sciences 24:15, pages 11875.
Crossref
Rocio Rivero, Mónica Inés Esteva, Erya Huang, Leylen Colmegna, Jaime Altcheh, Ulrike Grossmann & Andrés Mariano Ruiz. (2023) ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment. PLOS Neglected Tropical Diseases 17:6, pages e0011440.
Crossref
Veronica G. Mendes, Lorena Rimolo, Ana Carolina B. de Lima, Roberto R. Ferreira, Luciano S. Oliveira, Lindice M. Nisimura, Samuel I. M. Horita, Andréa R. Costa, Gilberto Marcelo S. da Silva, Luiz Henrique C. Sangenis, Fernanda S. N. S. Mendes, Andrea S. Sousa, Henrique H. Veloso, Marcelo T. Holanda, Mauro F. F. Mediano, Mariana C. Waghabi, Luciana R. Garzoni, Otacílio C. Moreira, Constança Britto, Ademir B. Cunha, Alejandro Marcel Hasslocher‐Moreno & Roberto M. Saraiva. (2023) Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease. Journal of the American Heart Association 12:12.
Crossref
Alba L. Montoya, Elisa G. Carvajal, Uriel Ortega-Rodriguez, Igor L. Estevao, Roger A. Ashmus, Sohan R. Jankuru, Susana Portillo, Cameron C. Ellis, Colin D. Knight, Julio Alonso-Padilla, Luis Izquierdo, Maria-Jesus Pinazo, Joaquim Gascon, Veronica Suarez, Douglas M. Watts, Iliana R. Malo, Janine M. Ramsey, Belkisyolé Alarcón De Noya, Oscar Noya, Igor C. Almeida & Katja Michael. (2022) A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease. Molecules 27:17, pages 5714.
Crossref
Anthony Man & Florencia Segal. 2022. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention.
Fernanda Lascano, Facundo García Bournissen & Jaime Altcheh. (2021) Review of pharmacological options for the treatment of Chagas disease. British Journal of Clinical Pharmacology 88:2, pages 383-402.
Crossref
Jose A. Pérez-Molina, Clara Crespillo-Andújar, Pau Bosch-Nicolau & Israel Molina. (2021) Trypanocidal treatment of Chagas disease. Enfermedades infecciosas y microbiologia clinica (English ed.) 39:9, pages 458-470.
Crossref
Jose A. Pérez-Molina, Clara Crespillo-Andújar, Pau Bosch-Nicolau & Israel Molina. (2021) Trypanocidal treatment of Chagas disease. Enfermedades Infecciosas y Microbiología Clínica 39:9, pages 458-470.
Crossref
Lu Su, Yingle Feng, Kongchang Wei, Xuyang Xu, Rongying Liu & Guosong Chen. (2021) Carbohydrate-Based Macromolecular Biomaterials. Chemical Reviews 121:18, pages 10950-11029.
Crossref
Subhadip Choudhuri, Suresh K. Bhavnani, Weibin Zhang, Valentina Botelli, Natalia Barrientos, Facundo Iñiguez, Maria Paola Zago & Nisha Jain Garg. (2021) Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy. Microbiology Spectrum 9:1.
Crossref
Julio Alonso-Padilla, Manuel Carlos López, Mónica Esteva, Maan Zrein, Aina Casellas, Inmaculada Gómez, Elodie Granjon, Susana Méndez, Celia Benítez, Andres Mariano Ruiz, Sergi Sanz, Joaquim Gascón, M Carmen Thomas, Maria-Jesus Pinazo, Marcelo Abril, Belkisyolé Alarcón de Noya, Tania Araujo Jorge, Eric Chatelain, Mario J. Grijalva, Felipe Guhl, Alejandro Marcel Hasslocher-Moreno, Alejandro O. Luquetti, Oscar Noya, Janine M. Ramsey, Isabela Ribeiro, Silvia A. Longhi, Alejandro G. Schijman, Sergio Sosa-Estani, Faustino Torrico & Rodolfo Viotti. (2021) Serological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.. Acta Tropica 221, pages 105990.
Crossref
Héctor O. Rodríguez‐Angulo, Andrés Lamsfus‐Calle, Javier Isoler‐Alcaráz, Javier Galán‐Martínez, Alfonso Herreros‐Cabello, Francisco Callejas‐Hernández, María A. Chorro‐de‐Villaceballos, María C. Maza, Julien Santi‐Rocca, Cristina Poveda, Javier Del Moral‐Salmoral, Juan Marques, Iván Mendoza, Juan David Ramírez, Felipe Guhl, Irene Carrillo, Ramón Pérez‐Tanoira, Miguel Górgolas, Ana Pérez‐Ayala, Begoña Monge‐Maillo, Francesca Norman, José A. Pérez‐Molina, Rogelio López‐Vélez, Manuel Fresno & Núria Gironès. (2021) Autoantibodies against the immunodominant sCha epitope discriminate the risk of sudden death in chronic Chagas cardiomyopathy. Annals of the New York Academy of Sciences 1497:1, pages 27-38.
Crossref
Nora Adriana Hernández-Cuevas, Andrea Marín-Cervera, Shineily Garcia-Polanco, Pedro Martínez-Vega, Miguel Rosado-Vallado & Eric Dumonteil. (2021) Fibronectin degradation as biomarker for Trypanosoma cruzi infection and treatment monitoring in mice . Parasitology 148:9, pages 1067-1073.
Crossref
Satabdi Datta Choudhury. (2021) Nano-Medicines a Hope for Chagas Disease!. Frontiers in Molecular Biosciences 8.
Crossref
Antonia Pino-Marín, Germán José Medina-Rincón, Sebastian Gallo-Bernal, Alejandro Duran-Crane, Álvaro Ignacio Arango Duque, María Juliana Rodríguez, Ramón Medina-Mur, Frida T. Manrique, Julian F. Forero & Hector M. Medina. (2021) Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death. Pathogens 10:5, pages 505.
Crossref
Sandra Parisi, Miriam Navarro, Jeremy Douglas Du Plessis, Jonathan Phillip Shock, Boris Apodaca Michel, Minerva Lucuy Espinoza, Carolina Terán, Nino Antonio Calizaya Tapia, Katharina Oltmanns, Abundio Baptista Mora, Claudia Saveedra Irala, Angel Alberto Rivera Rojas, Gonzalo Rubilar, Thomas Zoller & Michael Pritsch. (2020) “We have already heard that the treatment doesn't do anything, so why should we take it?”: A mixed method perspective on Chagas disease knowledge, attitudes, prevention, and treatment behaviour in the Bolivian Chaco. PLOS Neglected Tropical Diseases 14:10, pages e0008752.
Crossref
Aroa Silgado, Zaira Moure, Maykon T de Oliveira, Núria Serre-Delcor, Fernando Salvador, Inés Oliveira, Israel Molina, Tomàs Pumarola, Juan C Ramírez & Elena Sulleiro. (2020) Comparison of DNA extraction methods and real-time PCR assays for the molecular diagnostics of chronic Chagas disease. Future Microbiology 15:12, pages 1139-1145.
Crossref
Nuria Cortes-Serra, Irene Losada-Galvan, María-Jesus Pinazo, Carmen Fernandez-Becerra, Joaquim Gascon & Julio Alonso-Padilla. (2020) State-of-the-art in host-derived biomarkers of Chagas disease prognosis and early evaluation of anti-Trypanosoma cruzi treatment response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:7, pages 165758.
Crossref
Chen Chao, José L. Leone & Carlos A. Vigliano. (2020) Chagas disease: Historic perspective. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:5, pages 165689.
Crossref
M.K. Lynn, Brian H. Bossak, Paul A. Sandifer, Annette Watson & Melissa S. Nolan. (2020) Contemporary autochthonous human Chagas disease in the USA. Acta Tropica 205, pages 105361.
Crossref
Julio Alonso-Padilla, Marcelo Abril, Belkisyolé Alarcón de Noya, Igor C. Almeida, Andrea Angheben, Tania Araujo Jorge, Eric Chatelain, Monica Esteva, Joaquim Gascón, Mario J. Grijalva, Felipe Guhl, Alejandro Marcel Hasslocher-Moreno, Manuel Carlos López, Alejandro Luquetti, Oscar Noya, María Jesús Pinazo, Janine M. Ramsey, Isabela Ribeiro, Andres Mariano Ruiz, Alejandro G. Schijman, Sergio Sosa-Estani, M. Carmen Thomas, Faustino Torrico, Maan Zrein & Albert Picado. (2020) Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. PLOS Neglected Tropical Diseases 14:4, pages e0008035.
Crossref
Luis Eduardo Echeverría, Rachel Marcus, Gabriel Novick, Sergio Sosa-Estani, Kate Ralston, Ezequiel Jose Zaidel, Colin Forsyth, Antonio Luiz P. Ribeiro, Iván Mendoza, Mariano Luis Falconi, Jorge Mitelman, Carlos A. Morillo, Ana Cristina Pereiro, María Jesús Pinazo, Roberto Salvatella, Felipe Martinez, Pablo Perel, Álvaro Sosa Liprandi, Daniel José Piñeiro & Gustavo Restrepo Molina. (2020) WHF IASC Roadmap on Chagas Disease. Global Heart 15:1, pages 26.
Crossref
Adriana Egui, Manuel Carlos López, Inmaculada Gómez, Marina Simón, Manuel Segovia & M. Carmen Thomas. (2020) Differential phenotypic and functional profile of epitope-specific cytotoxic CD8+ T cells in benznidazole-treated chronic asymptomatic Chagas disease patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:3, pages 165629.
Crossref
Julio A. Urbina. 2020. Chagas Disease. Chagas Disease 123 144 .
Montserrat Gállego, Alejandro G. Schijman & Julio Alonso-Padilla. 2020. Chagas Disease. Chagas Disease 75 94 .
Noelia Floridia-YapurMercedes Monje-RumiPaula RagoneJuan J. LauthierNicolás TomasiniAnahí Alberti D’AmatoPatricio DiosqueRubén CiminoJosé F. GilDaniel O. Sanchez, Julio R. NasserValeria Tekiel. (2019) TcTASV Antigens of Trypanosoma cruzi: Utility for Diagnosis and High Accuracy as Biomarkers of Treatment Efficacy in Pediatric Patients. The American Journal of Tropical Medicine and Hygiene 101:5, pages 1135-1138.
Crossref
Adriana Egui, M. Carmen Thomas, Ana Fernández-Villegas, Elena Pérez-Antón, Inmaculada Gómez, Bartolomé Carrilero, Ángel del Pozo, Maialen Ceballos, Eduardo Andrés-León, Miguel Ángel López-Ruz, Eusebio Gainza, Enrique Oquiñena, Manuel Segovia & Manuel Carlos López. (2019) A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Antimicrobial Agents and Chemotherapy 63:10.
Crossref
Ana Catarina Cristovão Silva, Maria Carolina Accioly Brelaz-de-Castro, Ana Cristina Lima Leite, Valéria Rêgo Alves Pereira & Marcelo Zaldini Hernandes. (2019) Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains. Frontiers in Pharmacology 10.
Crossref
Rudy Parrado, Juan Carlos Ramirez, Anabelle de la Barra, Cristina Alonso-Vega, Natalia Juiz, Lourdes Ortiz, Daniel Illanes, Faustino Torrico, Joaquim Gascon, Fabiana Alves, Laurence Flevaud, Lineth Garcia, Alejandro G. Schijman & Isabela Ribeiro. (2019) Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease. Antimicrobial Agents and Chemotherapy 63:2.
Crossref
Alejandro O. Luquetti & Alejandro G. Schijman. 2019. Chagas Disease. Chagas Disease 141 158 .
Elizabeth Ruiz-Lancheros, Eric Chatelain & Momar Ndao. 2019. Chagas Disease. Chagas Disease 323 349 .
Héctor Freilij. 2019. Chagas Disease. Chagas Disease 3 22 .
Julio Alonso-Padilla, Dolors Tassies, Nuria Cortes-Serra, Joaquim Gascon, Joan-Carles Reverter & María-Jesús Pinazo. 2019. T. cruzi Infection. T. cruzi Infection 275 286 .
Elizabeth Ruiz-Lancheros, Asieh Rasoolizadeh, Eric Chatelain, Facundo Garcia-Bournissen, Samanta Moroni, Guillermo Moscatelli, Jaime Altcheh & Momar Ndao. (2018) Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole. Open Forum Infectious Diseases 5:11.
Crossref
Maria Carmo Pereira Nunes, Andrea Beaton, Harry Acquatella, Caryn Bern, Ann F. Bolger, Luis E. Echeverría, Walderez O. Dutra, Joaquim Gascon, Carlos A. Morillo, Jamary Oliveira-Filho, Antonio Luiz Pinho Ribeiro & Jose Antonio Marin-Neto. (2018) Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation 138:12.
Crossref
Sheba Meymandi, Salvador Hernandez, Sandy Park, Daniel R. Sanchez & Colin Forsyth. (2018) Treatment of Chagas Disease in the United States. Current Treatment Options in Infectious Diseases 10:3, pages 373-388.
Crossref
Alejandro G. Schijman. (2018) Molecular diagnosis of Trypanosoma cruzi. Acta Tropica 184, pages 59-66.
Crossref
Elena Pérez-Antón, Adriana Egui, M. Carmen Thomas, Concepción J. Puerta, John Mario González, Adriana Cuéllar, Manuel Segovia & Manuel Carlos López. (2018) Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients. PLOS Neglected Tropical Diseases 12:5, pages e0006480.
Crossref
Faustino Torrico, Joaquim Gascon, Lourdes Ortiz, Cristina Alonso-Vega, María-Jesús Pinazo, Alejandro Schijman, Igor C Almeida, Fabiana Alves, Nathalie Strub-Wourgaft, Isabela Ribeiro, Glaucia Santina, Bethania Blum, Erika Correia, Facundo Garcia-Bournisen, Michel Vaillant, Jimena Ramos Morales, Jimy Jose Pinto Rocha, Gimena Rojas Delgadillo, Helmut Ramon Magne Anzoleaga, Nilce Mendoza, Roxana Challapa Quechover, Maria Yurly Escobar Caballero, Daniel Franz Lozano Beltran, Albert Mendoza Zalabar, Lizeth Rojas Panozo, Alejandro Palacios Lopez, Dunia Torrico Terceros, Violeta Alejandra Fernandez Galvez, Letty Cardozo, Gabriela Cuellar, Rudy Nelson Vasco Arenas, Isabel Gonzales, Carlos Florencio Hoyos Delfin, Lineth Garcia, Rudy Parrado, Anabelle de la Barra, Nair Montano, Sandro Villarroel, Tomas Duffy, Margarita Bisio, Juan Carlos Ramirez, Fred Duncanson, Michael Everson, Antonia Daniels, Makoto Asada, Eugene Cox, David Wesche, Paul Matthias Diderichsen, Alexandre F Marques, Luis Izquierdo, Silvia Sanz Sender, Joan Carlos Reverter, Manuel Morales & Wladimiro Jimenez. (2018) Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. The Lancet Infectious Diseases 18:4, pages 419-430.
Crossref
Maan Zrein, Elodie Granjon, Lucie Gueyffier, Julie Caillaudeau, Peter Liehl, Hans Pottel, Clareci Silva Cardoso, Claudia Di Lorenzo Oliveira, Lea Campos de Oliveira, Tzong-Hae Lee, Ariela Mota Ferreira, Antonio Luiz P. Ribeiro, Michael P. Busch & Ester Cerdeira Sabino. (2018) A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients. PLOS Neglected Tropical Diseases 12:2, pages e0006226.
Crossref
Lígia Camera Pierrotti, Noemia Barbosa Carvalho, Jimena Prieto Amorin, Julio Pascual, Camille N. Kotton & Rogelio López-Vélez. (2018) Chagas Disease Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 102:2S, pages S1-S7.
Crossref
José A Pérez-Molina & Israel Molina. (2018) Chagas disease. The Lancet 391:10115, pages 82-94.
Crossref
Simon L. CroftEric Chatelain & Michael P. Barrett. (2017) Antileishmanial and antitrypanosomal drug identification. Emerging Topics in Life Sciences 1:6, pages 613-620.
Crossref
Virginia Balouz, Luciano J. Melli, Romina Volcovich, Guillermo Moscatelli, Samanta Moroni, Nicolás González, Griselda Ballering, Margarita Bisio, Andrés E. Ciocchini, Carlos A. Buscaglia & Jaime Altcheh. (2017) The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease. Journal of Clinical Microbiology 55:12, pages 3444-3453.
Crossref
Juan C. Ramírez, Rudy Parrado, Elena Sulleiro, Anabelle de la Barra, Marcelo Rodríguez, Sandro Villarroel, Lucía Irazu, Cristina Alonso-Vega, Fabiana Alves, María A. Curto, Lineth García, Lourdes Ortiz, Faustino Torrico, Joaquim Gascón, Laurence Flevaud, Israel Molina, Isabela Ribeiro & Alejandro G. Schijman. (2017) First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease. PLOS ONE 12:11, pages e0188550.
Crossref
María-Isabel Rocha-Gaso, Luis-Jesús Villarreal-Gómez, Denis Beyssen, Frédéric Sarry, Marco-Antonio Reyna & Carlos-Napoleón Ibarra-Cerdeña. (2017) Biosensors to Diagnose Chagas Disease: A Brief Review. Sensors 17:11, pages 2629.
Crossref
Carolina I. Cura, Juan C. Ramírez, Marcelo Rodríguez, Constanza Lopez-Albízu, Lucía Irazu, Karenina Scollo & Sergio Sosa-Estani. (2017) Comparative Study and Analytical Verification of PCR Methods for the Diagnosis of Congenital Chagas Disease. The Journal of Molecular Diagnostics 19:5, pages 673-681.
Crossref
Susana A. Besuschio, Mónica Llano Murcia, Alejandro F. Benatar, Severine Monnerat, Israel Cruz, Albert Picado, María de los Ángeles Curto, Yutaka Kubota, Diana P. Wehrendt, Paula Pavia, Yasuyoshi Mori, Concepción Puerta, Joseph M. Ndung'u & Alejandro G. Schijman. (2017) Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples. PLOS Neglected Tropical Diseases 11:7, pages e0005779.
Crossref
Eric Dumonteil & Claudia Herrera. (2017) Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges. PLOS Neglected Tropical Diseases 11:4, pages e0005422.
Crossref
Jose Mateus, Elena Pérez-Antón, Paola Lasso, Adriana Egui, Nubia Roa, Bartolomé Carrilero, John M. González, M. Carmen Thomas, Concepción J. Puerta, Manuel C. López & Adriana Cuéllar. (2017) Antiparasitic Treatment Induces an Improved CD8+ T Cell Response in Chronic Chagasic Patients. The Journal of Immunology 198:8, pages 3170-3180.
Crossref
Paula Sartor, Ivana Colaianni, M. Victoria Cardinal, Jacqueline Bua, Héctor Freilij & Ricardo E. Gürtler. (2017) Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation. PLOS Neglected Tropical Diseases 11:2, pages e0005336.
Crossref
Carlos A. Morillo, Hetty Waskin, Sergio Sosa-Estani, Maria del Carmen Bangher, Carlos Cuneo, Rodolfo Milesi, Marcelo Mallagray, Werner Apt, Juan Beloscar, Joaquim Gascon, Israel Molina, Luis E. Echeverria, Hugo Colombo, Jose Antonio Perez-Molina, Fernando Wyss, Brandi Meeks, Laura R. Bonilla, Peggy Gao, Bo Wei, Michael McCarthy, Salim Yusuf, Carlos Morillo, Sergio Sosa-Estani, Hetty Waskin, Brandi Meeks, Salim Yusuf, Rafael Diaz, Harry Acquatella, Julio Lazzari, Robin Roberts, Mahmoud Traina, Brandi Meeks, Laura R. Bonilla, Peggy Gao, Amanda Taylor, Iris Holadyk-Gris, Lindsey Whalen, M.C. Bangher, M.A. Romero, N. Prado, Y. Hernández, M. Fernandez, A. Riarte, K. Scollo, C. Lopez-Albizu, C.A. Cuneo, N.C. Gutiérrez, R.R. Milesi, M.A. Berli, M.H. Mallagray, N.E. Cáceres, J.S. Beloscar, J.M. Petrucci, H. Colombo, M. Dellatorre, Aldo Prado, W. Apt, I. Zulantay, L.E. Echeverría, D. Isaza, E. Reyes, F.S. Wyss, A. Figueroa, I. Guzmán Melgar, E. Rodríguez, J. Gascon, E. Aldasoro, E.J. Posada, N. Serret, I. Molina, A. Sánchez-Montalvá, J.A. Perez-Molina, R. López-Vélez & P.A. Reyes-López. (2017) Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic  T. Cruzi Carriers. Journal of the American College of Cardiology 69:8, pages 939-947.
Crossref
Caryn Bern. (2017) A New Epoch in Antitrypanosomal Treatment for Chagas Disease ∗. Journal of the American College of Cardiology 69:8, pages 948-950.
Crossref
Albert Picado, Andrea Angheben, Andrea Marchiol, Belkisyolé Alarcón de Noya, Laurence Flevaud, Maria Jesus Pinazo, Montserrat Gállego, Sheba Meymandi & Silvia Moriana. (2017) Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?. PLOS Neglected Tropical Diseases 11:1, pages e0005148.
Crossref
Eric Chatelain. (2017) Chagas disease research and development: Is there light at the end of the tunnel?. Computational and Structural Biotechnology Journal 15, pages 98-103.
Crossref
V. Balouz, F. Agüero & C.A. Buscaglia. 2017. 1 45 .
F. Fernandes, C.H. Valente Moreira, J.M. Barbosa-Ferreira & E.C. Sabino. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases 553 574 .
Alejandro Vallejo, Begoña Monge-Maillo, Carolina Gutiérrez, Francesca F. Norman, Rogelio López-Vélez & José A. Pérez-Molina. (2016) Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease. Acta Tropica 164, pages 117-124.
Crossref
Rosa T. Pinho, Mariana C. Waghabi, Fabíola Cardillo, José Mengel & Paulo R. Z. Antas. (2016) Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!. Frontiers in Immunology 7.
Crossref
Ana Fernandez-Villegas, M. Carmen Thomas, Bartolomé Carrilero, Paola Lasso, Adriana Egui, Laura Murcia, Manuel Segovia, Carlos Alonso & Manuel Carlos López. (2016) A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease . Journal of Antimicrobial Chemotherapy 71:7, pages 2005-2009.
Crossref
Leticia L Niborski, Vanina Grippo, Sonia O Lafón, Gabriela Levitus, Facundo García-Bournissen, Juan C Ramirez, Juan M Burgos, Margarita Bisio, Natalia A Juiz, Vilma Ayala, María Coppede, Verónica Herrera, Crescencia López, Ana Contreras, Karina A Gómez, Juan C Elean, Hugo D Mujica, Alejandro G Schijman, Mariano J Levin & Silvia A Longhi. (2016) Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina. Memórias do Instituto Oswaldo Cruz 111:6, pages 365-371.
Crossref
María G. Alvarez, Graciela L. Bertocchi, Gretchen Cooley, María C. Albareda, Rodolfo Viotti, Damián E. Perez-Mazliah, Bruno Lococo, Melisa Castro Eiro, Susana A. Laucella & Rick L. Tarleton. (2016) Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses. PLOS Neglected Tropical Diseases 10:4, pages e0004657.
Crossref
Myllena F Melo, Otacilio C Moreira, Priscila Tenório, Virginia Lorena, Izaura Lorena-Rezende, Wilson Oliveira Júnior, Yara Gomes & Constança Britto. (2015) Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients. Parasites & Vectors 8:1.
Crossref
Maria Roura, Andreu Domingo, Juan M Leyva-Moral & Robert Pool. (2015) Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review. BMC Public Health 15:1.
Crossref
Jose A Pérez-Molina, Angela Martinez Perez, Francesca F Norman, Begoña Monge-Maillo & Rogelio López-Vélez. (2015) Old and new challenges in Chagas disease. The Lancet Infectious Diseases 15:11, pages 1347-1356.
Crossref
Yanina Sguassero, Cristina B. Cuesta, Karen N. Roberts, Elizabeth Hicks, Daniel Comandé, Agustín Ciapponi & Sergio Sosa-Estani. (2015) Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. PLOS ONE 10:10, pages e0139363.
Crossref
Juan Carlos Ramírez, Carolina Inés Cura, Otacilio da Cruz Moreira, Eliane Lages-Silva, Natalia Juiz, Elsa Velázquez, Juan David Ramírez, Anahí Alberti, Paula Pavia, María Delmans Flores-Chávez, Arturo Muñoz-Calderón, Deyanira Pérez-Morales, José Santalla, Paulo Marcos da Matta Guedes, Julie Peneau, Paula Marcet, Carlos Padilla, David Cruz-Robles, Edward Valencia, Gladys Elena Crisante, Gonzalo Greif, Inés Zulantay, Jaime Alfredo Costales, Miriam Alvarez-Martínez, Norma Edith Martínez, Rodrigo Villarroel, Sandro Villarroel, Zunilda Sánchez, Margarita Bisio, Rudy Parrado, Lúcia Maria da Cunha Galvão, Antonia Cláudia Jácome da Câmara, Bertha Espinoza, Belkisyole Alarcón de Noya, Concepción Puerta, Adelina Riarte, Patricio Diosque, Sergio Sosa-Estani, Felipe Guhl, Isabela Ribeiro, Christine Aznar, Constança Britto, Zaida Estela Yadón & Alejandro G. Schijman. (2015) Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients. The Journal of Molecular Diagnostics 17:5, pages 605-615.
Crossref
Caryn Bern. (2015) Chagas’ Disease. New England Journal of Medicine 373:5, pages 456-466.
Crossref
Analía I. Porrás, Zaida E. Yadon, Jaime Altcheh, Constança Britto, Gabriela C. Chaves, Laurence Flevaud, Olindo Assis Martins-Filho, Isabela Ribeiro, Alejandro G. Schijman, Maria Aparecida Shikanai-Yasuda, Sergio Sosa-Estani, Eric Stobbaerts & Fabio Zicker. (2015) Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment. PLOS Neglected Tropical Diseases 9:6, pages e0003697.
Crossref
Maria-Jesus Pinazo, Maria-Carmen Thomas, Juan Bustamante, Igor Correia de Almeida, Manuel-Carlos Lopez & Joaquim Gascon. (2015) Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives. Memórias do Instituto Oswaldo Cruz 110:3, pages 422-432.
Crossref
Virginia Balouz, María de los Milagros Cámara, Gaspar E. Cánepa, Santiago J. Carmona, Romina Volcovich, Nicolás Gonzalez, Jaime Altcheh, Fernán Agüero & Carlos A. Buscaglia. (2015) Mapping Antigenic Motifs in the Trypomastigote Small Surface Antigen from Trypanosoma cruzi. Clinical and Vaccine Immunology 22:3, pages 304-312.
Crossref
Eric Chatelain. (2015) Chagas Disease Drug Discovery: Toward a New Era. SLAS Discovery 20:1, pages 22-35.
Crossref
Marta de Lana & Olindo Assis Martins-Filho. (2015) Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?. BioMed Research International 2015, pages 1-10.
Crossref
Julio A. Urbina. (2015) Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives. Journal of Eukaryotic Microbiology 62:1, pages 149-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.